{
    "eid": "2-s2.0-85017132112",
    "title": "Correction of Vitamin D deficiency facilitated suppression of IP-10 and DPP IV levels in patients with chronic hepatitis C: A randomised double-blinded, placebo-control trial",
    "cover-date": "2017-04-01",
    "subject-areas": [
        {
            "$": "Multidisciplinary",
            "@code": "1000"
        }
    ],
    "keywords": [],
    "authors": [
        "Piyawat Komolmit"
    ],
    "citedby-count": 32,
    "ref-count": 43,
    "ref-list": [
        "Hepatitis C virus infection",
        "Natural history and risk factors for progression of hepatitis C virus disease and development of hepatocellular cancer before liver transplantation",
        "2011 European Association of the Study of the Liver hepatitis C virus clinical practice guidelines",
        "Low vitamin d serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C",
        "Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus",
        "Innate and adaptive immune responses in HCV infections",
        "Vitamin D and the immune system: New perspectives on an old theme",
        "Medical progress: Vitamin D deficiency",
        "Common genetic determinants of vitamin D insufficiency: A genome-wide association study",
        "IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection",
        "Expression of IFN-lnducible protein-10 in chronic hepatitis",
        "Association between CXCL10 and DPP4 gene polymorphisms and a complementary role for unfavorable IL28B genotype in prediction of treatment response in Thai patients with chronic hepatitis C virus infection",
        "Effects of vitamin D3 on expression of tumor necrosis factor-\u03b1 and chemokines by monocytes",
        "Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV",
        "Evaluation, treatment, and prevention of vitamin D deficiency: An endocrine society clinical practice guideline",
        "CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.",
        "Vitamin D and inflammation",
        "Statistical Power Analysis for the Behavioral Sciences",
        "A genetic validation study reveals a role of vitamin D metabolism in the response to interferon-alfa-based therapy of chronic hepatitis C",
        "Association of vitamin D serum levels and its common genetic determinants, with severity of liver fibrosis in genotype 1 chronic hepatitis C patients",
        "Complementary role of vitamin D deficiency and the interleukin-28B rs12979860 C/T polymorphism in predicting antiviral response in chronic hepatitis C",
        "Vitamin D binding protein gene polymorphisms and baseline vitamin D levels as predictors of antiviral response in chronic hepatitis C",
        "Relationship of vitamin D status with advanced liver fibrosis and response to hepatitis C virus therapy: A meta-analysis",
        "Vitamin D and the racial difference in the genotype 1 chronic hepatitis C treatment response",
        "Vitamin D supplementation improves response to antiviral treatment for recurrent hepatitis C",
        "IL28B polymorphisms, IP-10 and viral load predict virological response to therapy in chronic hepatitis C",
        "Vitamin D: An innate antiviral agent suppressing hepatitis C virus in human hepatocytes",
        "Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver",
        "1(OH) Vitamin D3 Supplementation Improves the Sensitivity of the Immune-Response during Peg-IFN/RBV Therapy in Chronic Hepatitis C Patients-Case Controlled Trial",
        "Interferon-induced gene expression is a stronger predictor of treatment response than IL28B genotype in patients with hepatitis C",
        "IL28 variation affects expression of interferon stimulated genes and peg-interferon and ribavirin therapy",
        "Interferon (IFN)-\u03b3-inducible protein-10: Association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-\u03b12a and ribavirin for chronic hepatitis C virus infection",
        "Changes of soluble CD26 and CD30 levels correlate with response to interferon plus ribavirin therapy in patients with chronic hepatitis C",
        "Impact of Soluble CD26 on Treatment Outcome and Hepatitis C Virus-Specific T Cells in Chronic Hepatitis C Virus Genotype 1 Infection",
        "Chemokine antagonism in chronic hepatitis C virus infection",
        "Altered endocrine and autocrine metabolism of vitamin D in a mouse model of gastrointestinal inflammation",
        null,
        "Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile",
        null,
        "Human Th17 cells express high levels of enzymatically active dipeptidylpeptidase IV (CD26)",
        "Detection of type 2-like T-helper cells in hepatitis C virus infection: Implications for hepatitis C virus chronicity",
        "CD30 Induction and Cytokine Profiles in Hepatitis C Virus Core-Specific Peripheral Blood T Lymphocytes",
        "Vitamin D and serum cytokines in a randomized clinical trial"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Thai Red Cross Agency",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Phisanulok",
            "affilname": "Buddhachinaraj Hospital",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": []
}